WALTHAM, Mass. -- Decision Resources, Inc., one of
the world's leading research and advisory firms focusing on pharmaceutical and
health care issues, finds that pressure from expert panels, payers, and public
health officials to reduce antibiotic overprescribing will limit growth of the
acute exacerbations of chronic bronchitis (AECB) drug market over the next
decade.
"AECB is currently overtreated with antibiotics, and experts suggest that
a subset of patients with minor symptoms probably do not require antibiotic
therapy," said Aarti Raja, PhD, an analyst at Decision Resources. "However,
because AECB patients often have multiple other medical problems, primary care
physicians tend to err on the side of caution and prescribe antibiotics-often
the 'latest and greatest'."
The new Pharmacor study, titled Acute Exacerbations of Chronic Bronchitis,
also finds that physicians are caught between a need to limit overprescribing
and a need to deal with increasing antibiotic resistance among respiratory
pathogens in the major pharmaceutical markets (United States, Germany, France,
Italy, Spain, Japan, and the United Kingdom). So far, attempts by managed care
organizations, insurers, and national health systems to contain the cost of
treating AECB have been thwarted in part by these new generations of resistant
bacteria.
During an acute exacerbation, breathing becomes much more difficult
because of further narrowing of the airways and secretion of large amounts of
mucus that is often thicker than usual. An acute exacerbation of chronic
bronchitis is associated with increased frequency and severity of coughing,
and is often accompanied by worsened chest congestion and discomfort.
Source: Decision Resources, Inc.
Beyond the Surface: Rethinking Environmental Hygiene Validation at Exchange25
June 30th 2025Environmental hygiene is about more than just shiny surfaces. At Exchange25, infection prevention experts urged the field to look deeper, rethink blame, and validate cleaning efforts across the entire care environment, not just EVS tasks.
A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides
June 26th 2025As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.
Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski
June 26th 2025In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.